Literature DB >> 9313605

Increased plasma tissue factor levels in acute myocardial infarction.

H Suefuji1, H Ogawa, H Yasue, K Kaikita, H Soejima, T Motoyama, Y Mizuno, S Oshima, T Saito, I Tsuji, K Kumeda, Y Kamikubo, S Nakamura.   

Abstract

BACKGROUND: Tissue factor (TF) is a low molecular weight glycoprotein that initiates the clotting cascade and is considered to be a major regulator of coagulation, hemostasis, and thrombosis. METHODS AND
RESULTS: We examined plasma TF levels in 31 consecutive patients with acute myocardial infarction (AMI) (within 6 hours after the onset of symptoms), 27 patients with stable exertional angina, and 27 control subjects. Ten patients with AMI had a history of unstable angina before infarction, and 21 had a sudden onset of infarction. The plasma TF level was higher in the AMI group than in the stable exertional angina and control groups (240 +/- 112 vs 184 +/- 46 pg/ml [p < 0.05] vs 177 +/- 37 pg/ml, p < 0.01, respectively). TF levels were decreased in the chronic phase (2 weeks after admission) compared with the acute phase of infarction (from 240 +/- 112 pg/ml to 222 +/- 97 pg/ml, p < 0.05). In addition, plasma TF levels were higher in patients with AMI with prodromal unstable angina than in patients with a sudden onset of infarction (300 +/- 169 pg/ml vs 212 +/- 57 pg/ml, p < 0.05). TF levels were similar in the acute and chronic phases in the patients with AMI with prodromal unstable angina (300 +/- 169 pg/ml vs 290 +/- 136 pg/ml, p = not significant) but were decreased in the chronic phase in the patients with AMI with sudden onset (from 212 +/- 57 pg/ml to 190 +/- 49 pg/ml, p < 0.05).
CONCLUSION: Increased plasma TF levels in patients with AMI may reflect enhanced intravascular procoagulant activity. The higher TF levels in patients with AMI with prodramol unstable angina may be associated with repeated episodes of myocardial ischemia and reperfusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313605     DOI: 10.1016/s0002-8703(97)70132-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  23 in total

1.  Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction.

Authors:  Marie-Geneviève Huisse; Emilie Lanoy; Didier Tcheche; Laurent J Feldman; Annie Bezeaud; Eduardo Anglès-Cano; Murielle Mary-Krause; Dominique de Prost; Marie-Claude Guillin; P Gabriel Steg
Journal:  Thromb Haemost       Date:  2007-08       Impact factor: 5.249

2.  Circulating microparticles and endogenous estrogen in newly menopausal women.

Authors:  M Jayachandran; R D Litwiller; W G Owen; V M Miller
Journal:  Climacteric       Date:  2009-04       Impact factor: 3.005

3.  Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers.

Authors:  Tatyana Levinas; Elizabeth Eshel; Adi Sharabi-Nov; Alon Marmur; Najib Dally
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

4.  Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.

Authors:  Angela Silveira; Daniela Scanavini; Susanna Boquist; Carl-Göran Ericsson; Mai-Lis Hellénius; Karin Leander; Ulf de Faire; John Ohrvik; Barry Woodhams; James H Morrissey; Anders Hamsten
Journal:  Thromb Res       Date:  2011-09-16       Impact factor: 3.944

5.  Blood-borne tissue factor: another view of thrombosis.

Authors:  P L Giesen; U Rauch; B Bohrmann; D Kling; M Roqué; J T Fallon; J J Badimon; J Himber; M A Riederer; Y Nemerson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 6.  Thrombin and vascular inflammation.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  Mol Cell Biochem       Date:  2011-08-23       Impact factor: 3.396

7.  Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.

Authors:  T Ogiichi; Y Hirashima; S Nakamura; S Endo; M Kurimoto; A Takaku
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

8.  Circulating thrombotic and haemostatic components in patients with coronary artery disease.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S S Payannavar; A P Walvalkar; R A Mokal; S M Mithbawkar; K V Kudalkar; A Abraham; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-02-10

9.  Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.

Authors:  Li Wang; Christine Miller; Robert F Swarthout; Mohan Rao; Nigel Mackman; Mark B Taubman
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

10.  Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction.

Authors:  Birgit A Steppich; Siegmund Lorenz Braun; Andreas Stein; Gabriele Demetz; Philip Groha; Albert Schömig; Nicolas von Beckerath; Adnan Kastrati; Ilka Ott
Journal:  Thromb J       Date:  2009-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.